273

The pharmaceutical lobby strongly opposed the Biden administration's plan to directly negotiate drug prices for 10 medications with Medicare. PhRMA argued this will hurt innovation, but advocates note that drug companies make 76% more than needed for R&D. Eliquis, which costs Medicare over $16 billion, will be subject to negotiations. The policy was enabled by the Inflation Reduction Act, which PhRMA spent millions lobbying against. PhRMA sued over the negotiations, but the DOJ moved to dismiss the case. Advocates believe this defeat of Big Pharma will not be the last as negotiations may expand to over 100 drugs in the future, greatly helping seniors and people with disabilities access affordable medications.

you are viewing a single comment's thread
view the rest of the comments
[-] jmcs@discuss.tchncs.de 31 points 1 year ago

Big Pharma: we need to charge extortion rates to pay for R&D

Public: oh, cool, so you are using that money to pay the research, and not taking half of it in management bonus?

Big Pharma: ...

Public: You are not pocketing half of it right, right?

Big Pharma: COMMUNISTS!!!! The CEO needs the 3rd yacht otherwise he'll refuse to sign on the research, do you want that?

[-] Tolookah@discuss.tchncs.de 23 points 1 year ago

Sounds like a CEO needs to stop ordering coffee and eating avocado toast.

[-] TheFerrango@lemmy.basedcount.com 16 points 1 year ago

Of course they’re not pocketing half of it. They’re pocketing the 75%

this post was submitted on 30 Aug 2023
273 points (100.0% liked)

Politics

10188 readers
663 users here now

In-depth political discussion from around the world; if it's a political happening, you can post it here.


Guidelines for submissions:

These guidelines will be enforced on a know-it-when-I-see-it basis.


Subcommunities on Beehaw:


This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago
MODERATORS